Adult-Onset Still Disease

Adult Male Adolescent [SDV]Life Sciences [q-bio] Middle Aged Prognosis 3. Good health Young Adult 03 medical and health sciences 0302 clinical medicine Fluorodeoxyglucose F18 Risk Factors Antirheumatic Agents Positron-Emission Tomography Ferritins Humans Original Study Female Radiopharmaceuticals Still's Disease, Adult-Onset Aged Retrospective Studies
DOI: 10.1097/md.0000000000000021 Publication Date: 2014-03-03T20:49:22Z
ABSTRACT
We conducted a retrospective observational study to describe cohort and identify the prognostic factors in adult-onset Still disease (AOSD). Patients enrolled this chart review fulfilled either Yamaguchi or Fautrel criteria. Candidate variables were analyzed with logistic unadjusted adjusted regression models. Fifty-seven patients seen internal medicine (75%) rheumatology (25%) departments over mean period of 8.4 years. The median time diagnosis was 4 months. course AOSD monocyclic 17 patients, polycyclic 25, chronic 15. assessment glycosylated ferritin (GF) 37 correlated early diagnosis. Nine 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) scans identified lymph nodes glands as main sites hypermetabolism. Complications frequent (n = 19), including reactive hemophagocytic syndrome 8). None 3 deaths could be attributed AOSD. Corticosteroid dependence, predicted by low GF level, occurred 23 (45%). A quarter received tumor necrosis factor-α blockers anakinra good tolerance. Fever >39.5°C predictive AOSD, while arthritis thrombocytopenia associated complicated respectively. youngest had highest risks resistance first-line treatments. remains difficult diagnose. Mortality is despite complications. 18FDG-PET value diagnostic approach. condition highly symptomatic evolved systemic whereas more progressive patterns
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (5)
CITATIONS (200)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....